Melanoma-intrinsic NR2F6 activity regulates antitumor immunity
Hyungsoo Kim(Sanford Burnham Prebys Medical Discovery Institute), Ze’ev A. Ronai(Cedars-Sinai Medical Center), Jean‐Christophe Marine(VIB-KU Leuven Center for Cancer Biology), Rabi Murad(Sanford Burnham Prebys Medical Discovery Institute), Victoria Klepsch(Innsbruck Medical University), Meenhard Herlyn(The Wistar Institute), Carl Pelz(Oregon Health & Science University), Gottfried Baier(Innsbruck Medical University), Curtis C. Harris(National Cancer Institute), Joanna Poźniak(VIB-KU Leuven Center for Cancer Biology), Eytan Ruppin(Cedars-Sinai Medical Center), Bhavik Dalal(National Cancer Institute), Rosalie C. Sears(Oregon Health & Science University), Yeqing Chen(The Wistar Institute), Eduard Sergienko(Sanford Burnham Prebys Medical Discovery Institute), Michael R. Jackson(Scripps Research Institute), Yongmei Feng(University of Arizona)
Cited by 14
Related Papers
MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon Adenocarcinoma
|JAMA|2008|1.6k
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
|Cell|2018|1.5k
Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability
|Genes & Development|2000|1.4k
Colorectal carcinoma antigens detected by hybridoma antibodies
|Somatic Cell and Molecular Genetics|1979|1.4k
A Tumorigenic Subpopulation with Stem Cell Properties in Melanomas
|Cancer Research|2005|1.3k